Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 May-Jun;35(3):1877-1880.
doi: 10.21873/invivo.12450.

Lung Cancer, Covid-19 Infections and Chemotherapy

Bogdan Haineala  1 , Anca Zgura  2 , Dumitru Cristinel Badiu  3 , Laura Iliescu  4 , Rodica Maricela Anghel  5 , Xenia Elena Bacinschi  5
Affiliations
Observational Study

Lung Cancer, Covid-19 Infections and Chemotherapy

Bogdan Haineala et al. In Vivo. 2021 May-Jun.

Abstract

Background/aim: The Covid-19 epidemic has severely strained health care systems across the globe. The impacts are multiple especially for patients cared for cancer. The Covid-19 epidemic has several impacts on the management of lung cancer patients. The aim of this work was to summarize the available epidemiological data on patients diagnosed with lung cancer infected with Covid-19 and describe the different strategies to improve the management of these patients by summarizing the recommendations in this area.

Patients and methods: The Teravolt cohort is an observational multicenter registry, including patients with non-small cell cancer, small cell cancer or mesothelioma but also epithelial tumors and a diagnosis of Covid-19. The Theravolt registry indicates an unexpectedly high mortality rate in patients with thoracic malignancies with COVID-19.

Results: Between March 26 and April 12, 2020, 200 patients treated in 8 countries were included. They had a performance status (PS) of 0-1 in 72% of cases, were smokers or ex-smokers in 81% of cases, had non-small cell cancer (76% of cases), were under treatment in 74% of cases, and the majority were first-line cases (57%). The hospitalization rate was 76% and the mortality rate 33%; only 10% of patients with criteria for intensive care hospitalization were admitted to the intensive care.

Conclusion: Data presented in this registry suggest a high mortality in patients with thoracic cancer and Covid-19. Therofere, the importance to create a safe healthcare system during Covid-19 pandemic is underlined along with the need for essential effective clinical service delivery to patients with lung cancer.

Keywords: Covid-19 infection; Lung cancer; chemotherapy; immunotherapy; recommendations.

PubMed Disclaimer

Conflict of interest statement

The Authors declare that they have no competing interests in relation to this study.

Similar articles

  • COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
    Garassino MC, Whisenant JG, Huang LC, Trama A, Torri V, Agustoni F, Baena J, Banna G, Berardi R, Bettini AC, Bria E, Brighenti M, Cadranel J, De Toma A, Chini C, Cortellini A, Felip E, Finocchiaro G, Garrido P, Genova C, Giusti R, Gregorc V, Grossi F, Grosso F, Intagliata S, La Verde N, Liu SV, Mazieres J, Mercadante E, Michielin O, Minuti G, Moro-Sibilot D, Pasello G, Passaro A, Scotti V, Solli P, Stroppa E, Tiseo M, Viscardi G, Voltolini L, Wu YL, Zai S, Pancaldi V, Dingemans AM, Van Meerbeeck J, Barlesi F, Wakelee H, Peters S, Horn L; TERAVOLT investigators. Garassino MC, et al. Lancet Oncol. 2020 Jul;21(7):914-922. doi: 10.1016/S1470-2045(20)30314-4. Epub 2020 Jun 12. Lancet Oncol. 2020. PMID: 32539942 Free PMC article.
  • Safety of lung cancer surgery during COVID-19 in a pandemic epicenter.
    Villena-Vargas J, Lutton EM, Mynard N, Nasar A, Voza F, Chow O, Lee B, Harrison S, Stiles BM, Port JL, Altorki NK. Villena-Vargas J, et al. J Thorac Cardiovasc Surg. 2022 Aug;164(2):378-385. doi: 10.1016/j.jtcvs.2021.11.092. Epub 2022 Mar 1. J Thorac Cardiovasc Surg. 2022. PMID: 35459540 Free PMC article.
  • A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry.
    Whisenant JG, Baena J, Cortellini A, Huang LC, Lo Russo G, Porcu L, Wong SK, Bestvina CM, Hellmann MD, Roca E, Rizvi H, Monnet I, Boudjemaa A, Rogado J, Pasello G, Leighl NB, Arrieta O, Aujayeb A, Batra U, Azzam AY, Unk M, Azab MA, Zhumagaliyeva AN, Gomez-Martin C, Blaquier JB, Geraedts E, Mountzios G, Serrano-Montero G, Reinmuth N, Coate L, Marmarelis M, Presley CJ, Hirsch FR, Garrido P, Khan H, Baggi A, Mascaux C, Halmos B, Ceresoli GL, Fidler MJ, Scotti V, Métivier AC, Falchero L, Felip E, Genova C, Mazieres J, Tapan U, Brahmer J, Bria E, Puri S, Popat S, Reckamp KL, Morgillo F, Nadal E, Mazzoni F, Agustoni F, Bar J, Grosso F, Avrillon V, Patel JD, Gomes F, Ibrahim E, Trama A, Bettini AC, Barlesi F, Dingemans AM, Wakelee H, Peters S, Horn L, Garassino MC, Torri V; TERAVOLT study group. Whisenant JG, et al. J Thorac Oncol. 2022 May;17(5):661-674. doi: 10.1016/j.jtho.2021.12.015. Epub 2022 Feb 1. J Thorac Oncol. 2022. PMID: 35121086 Free PMC article.
  • Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave.
    Bertaglia V, Reale ML, Bironzo P, Palesandro E, Mariniello A, Leone G, Tabbò F, Bungaro M, Audisio M, Rapetti S, Di Stefano RF, Carnio S, Artusio E, Capelletto E, Sperone P, Passiglia F, Novello S. Bertaglia V, et al. Crit Rev Oncol Hematol. 2021 Jan;157:103189. doi: 10.1016/j.critrevonc.2020.103189. Epub 2020 Nov 27. Crit Rev Oncol Hematol. 2021. PMID: 33341505 Free PMC article. Review.
  • Surgical management of lung cancer during the COVID-19 pandemic - a narrative review and single-centre report.
    Werner RS, Lörtscher A, Kirschner MB, Lauk O, Furrer K, Caviezel C, Schneiter D, Inci I, Hillinger S, Curioni-Fontecedro A, Opitz I. Werner RS, et al. Swiss Med Wkly. 2022 Feb 7;152:w30109. doi: 10.4414/smw.2022.w30109. eCollection 2022 Jan 31. Swiss Med Wkly. 2022. PMID: 35147390 Review.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. Buccheri G, Ferrigno D. Lung cancer: Clinical presentation and specialist referral time. Eur Respir J. 2004;24(6):898–904. doi: 10.1183/09031936.04.00113603. - DOI - PubMed
    1. Larsen JE, Minna JD. Molecular biology of lung cancer: Clinical implications. Clin Chest Med. 2011;32(4):703–740. doi: 10.1016/j.ccm.2011.08.003. - DOI - PMC - PubMed
    1. Robilotti EV, Babady NE, Mead PA, Rolling T, Perez-Johnston R, Bernardes M, Bogler Y, Caldararo M, Figueroa CJ, Glickman MS, Joanow A, Kaltsas A, Lee YJ, Lucca A, Mariano A, Morjaria S, Nawar T, Papanicolaou GA, Predmore J, Redelman-Sidi G, Schmidt E, Seo SK, Sepkowitz K, Shah MK, Wolchok JD, Hohl TM, Taur Y, Kamboj M. Determinants of COVID-19 disease severity in patients with cancer. Nat Med. 2020;26(8):1218–1223. doi: 10.1038/s41591-020-0979-0. - DOI - PMC - PubMed
    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, China Novel Coronavirus Investigating and Research Team A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi: 10.1056/NEJMoa2001017. - DOI - PMC - PubMed
    1. Knight SR, Ho A, Pius R, Buchan I, Carson G, Drake TM, Dunning J, Fairfield CJ, Gamble C, Green CA, Gupta R, Halpin S, Hardwick HE, Holden KA, Horby PW, Jackson C, Mclean KA, Merson L, Nguyen-Van-Tam JS, Norman L, Noursadeghi M, Olliaro PL, Pritchard MG, Russell CD, Shaw CA, Sheikh A, Solomon T, Sudlow C, Swann OV, Turtle LC, Openshaw PJ, Baillie JK, Semple MG, Docherty AB, Harrison EM, ISARIC4C Investigators Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: Development and validation of the 4C mortality score. BMJ. 2020;370:m3339. doi: 10.1136/bmj.m3339. - DOI - PMC - PubMed

Publication types